Crossmark

Comparative in vitro assessment of CYP2C19 inhibition by ilaprazole and conventional proton pump inhibitors using a high throughput fluorometric assay

Crossref DOI link: https://doi.org/10.1038/s41598-025-02872-5

Published Online: 2025-05-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Priyadharshini, A. https://orcid.org/0000-0002-7936-6093
Vijayakumar, T. M.

Damodharan, N. https://orcid.org/0000-0003-4246-5351
Vasanth, K. M.

Elaiyaraja, Arun
Funding

Funding for this research was provided by:

SRM Institute of Science & Technology
License Information

Text and Data Mining valid from 2025-05-25

Version of Record valid from 2025-05-25
More Information

Article History

Received: 2 December 2024

Accepted: 16 May 2025

First Online: 25 May 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below